Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 19, 2018

SELL
$7.8 - $13.69 $168,565 - $295,854
-21,611 Closed
0 $0
Q3 2017

Oct 19, 2017

BUY
$12.17 - $16.3 $263,005 - $352,259
21,611
21,611 $266,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Round Table Services, LLC Portfolio

Follow Round Table Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Round Table Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Round Table Services, LLC with notifications on news.